Hi,
I haven't been her in a long long time. I'm in the U.S. but found this to be the best support resource for me. My son was dx'd with CML in 2008 at the age of 10. He's now about to turn 15. He's been taking Gleevec 400mg since dx. He's at MMR & his IRIS score is .00031.
My son has sort of levelled off as his numbers aren't going down any further. My father (who attends the International Hematology Conferences every year) is pushing for a TKI switch to Nilotinib. My father's view is that if my son reaches CMR and holds it for 2 years, then he can stop all TKIs. His view is that Nilotinib brings a deeper response - which is better even if my son continues on maintenance therapy.
My son and I will be seeing Dr. Brian Druker in a few weeks and I wanted to discuss the possibility of switching TKIs.
Can anyone share any thoughts on switching TKIs? I've read about rash with Nilotinib. Right now, my son's only side effect is terrible fatigue. He may have a resorption issue too because he fx'd his spine recently and last year, he broke his femur. I'm not certain about that, however.
Any thoughts would be so greatly appreciated! Thanks so much.
Tracey